BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (4), 1611-1617
- https://doi.org/10.2353/ajpath.2010.100212
Abstract
No abstract availableKeywords
Funding Information
- Gynecologic Cancer Foundation; the National Institutes of Health, including The University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence in Ovarian Cancer (P50 CA08369, R01-CA133057)
- MD Anderson's Cancer Center Support (CA016672)
This publication has 47 references indexed in Scilit:
- Ovarian Low-grade and High-grade Serous CarcinomaAdvances in Anatomic Pathology, 2009
- 14-3-3σ gene silencing during melanoma progression and its role in cell cycle control and cellular senescenceMolecular Cancer, 2009
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade CarcinomasCancer Research, 2009
- Ovarian CancerAnnual Review Of Pathology-Mechanisms Of Disease, 2009
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- Comparison of the clinical behavior of newly diagnosed stages II–IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinomaGynecologic Oncology, 2007
- Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumorsCancer Genetics and Cytogenetics, 2006
- Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP ArraysPLoS Computational Biology, 2006
- Molecular determinants of tumor differentiation in papillary serous ovarian carcinomaMolecular Carcinogenesis, 2003
- Identification of FOXC1 as a TGF-β1 Responsive Gene and Its Involvement in Negative Regulation of Cell GrowthGenomics, 2002